Researcher holding up a culture dish in each hand

Search newsletter

What's inside? See our latest issue

"Search" is our twice-yearly newsletter to supporters.

In our latest edition of Spring Search issue, we look at the latest research news including how our scientists are developing improved breast cancer tools that will help identify women at high risk and our pioneering trial to test multiple treatments for brain cancer.

We also introduce Dr Ben O'Leary, who is leading the newly formed Evolution and Translational Genomics Group. With his team, he is primarily investigating how head and neck cancers evolve and develop resistance to treatment.

For instant access to our latest issue of Search, simply subscribe by completing the form below. 

Sign up now to receive Search

Loading...
Title
Are you also happy for us to use the above details to send you any additional updates and opportunities to support our work?
"I look forward to getting my copy of Search. It’s great to read all about the excellent work that the ICR does and it reminds me why I decided to support them in the first place."
- James Wilding, donor

Newsletter archive

Search issue 50 - Autumn 2024

In our 50th edition of the Autumn Search issue, we look at the latest research news featuring a new breast cancer drug approval in the UK, for treating the most common type of advanced breast cancer.

Download issue 50 (PDF)

Search issue 49 – Spring 2024

Look at how our researchers received a prestigious Queen's Anniversary Prize on behalf of the ICR, in recognition of our transformational breast cancer research programme.

Download issue 49 (PDF)

Search issue 48 – Autumn 2023

Find out how we're transforming treatment for people with cancers of unmet need, and meet our family charity partner Siobhan's Superstar Legacy, whose generous donation is supporting the work of our new Team Leader in Developmental Oncology, Dr Sally George.

Download issue 48 (PDF)

Search issue 47 – Spring 2023

Meet Dr Stephen-John Sammut, whose research uses AI to forecast how cancer is likely to respond to treatment, and find out more about capivasertib, a new promising drug born from the ICR’s cutting-edge science and pioneering programme of clinical trials.

Download issue 47 (PDF)

Search issue 46 – Autumn 2022

Meet the Director of our Centre for Evolution and Cancer, Professor Trevor Graham, whose research uses evolutionary principles and computational modelling to reveal how cancer develops.

Download issue 46 (PDF)

Search issue 45 – Spring 2022

Meet our new Team Leader, Dr Alex Radzisheuskaya, whose research focusses on how proteins help to package up DNA in cells – and the role that this can play in cancer.

Download issue 45 (PDF)

 

28/02/25 - by

The Institute of Cancer Research, London, is delighted to welcome the new London Growth Plan, launched by Mayor of London Sadiq Khan , which places life sciences at the forefront of an ambitious strategy to boost the capital’s economic growth.

The Institute of Cancer Research (ICR) is a key partner at The London Cancer Hub, one of a consortium of ‘innovation clusters’ from across London, who are already working collaboratively to meet many of the goals laid out in the mayor’s plan.

London is already considered to be one of the leading cities in Europe for life sciences and other innovative scientific areas, including tech and artificial intelligence. However, the new Plan will further support and boost the growth of specialist life science clusters – ‘walkable’ districts that bring together partners from sectors including academic research, investors, startups, corporates and, for life sciences, hospitals.

Along with The London Cancer Hub, the other clusters to welcome the launch of the new plan are Barts Life Sciences, Whitechapel, Canary Wharf Life Sciences and Healthcare, The Knowledge Quarter, Olympic Park Innovation District, Paddington Life Sciences and White City Innovation District.

The innovation clusters are now looking forward to working with the Mayor's Office and other stakeholders to deliver the actions set out in the plan.

Dr Jon Wilkinson, Director of Business and Innovation, at The Institute of Cancer Research, London, said:

“London is one of the best places in Europe for companies in the life-sciences to spin out and start up – thanks to factors including the excellence of London’s universities, the possibility of partnerships with the NHS, the ready availability of lab space, and the availability of funding for new companies thanks to the presence of the City of London.

 “So, we’re delighted to see the new London Growth Plan recognising the strength of our life-sciences sector in London, and especially measures aimed at stimulating growth through supporting innovation at frontier innovation clusters. We're especially pleased to see The London Cancer Hub referenced in the plan – this is an oncology-focused district in Sutton, where we're working with partners including Sutton Council, developers Socius, and Aviva to generate new commercial partnerships, create jobs, stimulate economic growth, and above all to create new treatments that benefit cancer patients.

Councillor Barry Lewis, Leader of Sutton Council, a leading partner at The London Cancer Hub, said: 

“Our vision for Sutton is to become the global centre for oncology in London. The life science sector will be pivotal to the future growth of the capital over the coming years, and I am delighted that the Mayor’s growth plan names the London Cancer Hub in Sutton as the key engine for this growth.

“The London Cancer Hub is already delivering life changing cancer drug discoveries alongside world-leading cancer care through the Institute of Cancer Research (a member institution of the University of London) and the Royal Marsden NHS Trust. A multi-million investment from Aviva working with developer Socius will further expand the district and will bring more commercial and community spaces.”